Recent advancements in the field of monoclonal antibody (mAb) treatments have shown a promising shift towards more effective cancer therapies. The 3E10 antibody, initially identified in autoimmune mouse studies focused on systemic lupus erythematosus, has emerged as a game-changer. Unlike
Hodgkin lymphoma, a rare but treatable blood cancer, primarily impacts younger individuals aged 20-40. Effective treatment is crucial, but so is the consideration of long-term health and quality of life for patients. Recent advancements in chemotherapy regimens have shown promise in reducing
Genital herpes continues to be a significant global health issue, affecting millions of individuals worldwide. Despite the high prevalence, the condition often remains under-discussed and inadequately addressed. While many individuals exhibit no or few symptoms, others suffer from painful genital
Alzheimer’s disease, a debilitating condition marked by progressive memory loss and cognitive decline, has long proven resistant to effective treatment, leaving millions of patients and their families searching for hope. Despite significant research efforts, traditional therapies targeting the
Researchers at the Perelman School of Medicine at the University of Pennsylvania have made a significant breakthrough in personalized medicine and cancer treatment. By using patient-derived glioblastoma (GBM) organoids, they have developed a method to model patient responses to CAR-T cell therapy
The presence of microplastics (MPs) in human blood has become a pressing concern, with potential implications for health, particularly in relation to blood coagulation and inflammatory markers. This article delves into the prevalence of MPs in human biological systems, their sources, and the health
Artificial intelligence (AI) is making significant strides in the healthcare sector, revolutionizing the way care is delivered. By automating various processes, AI is not only reducing administrative burdens but also reinforcing the traditional patient-provider care model. This transformation is
Newcells Biotech, a leading partner in drug discovery recognized for its development of in vitro models and custom assay services, has recently announced a significant milestone by securing an additional £1.2 million in funding from its current investors, including Mercia Ventures, Northstar
The year 2024 has been a tumultuous one for Health New Zealand - Te Whatu Ora's Data & Digital division, with the organization grappling with numerous challenges ranging from significant budget cuts to leadership upheavals. These issues have hindered the much-needed advancements in the country's
Harnessing the power of artificial intelligence (AI), researchers have unlocked the potential of whole-body magnetic resonance imaging (MRI) to predict health risks, paving the way for smarter, personalized prevention strategies. This breakthrough is highlighted in a recent study published in the
